<DOC>
	<DOCNO>NCT00035178</DOCNO>
	<brief_summary>The primary goal investigation provide guidance dose Argatroban patient undergo hemodialysis ass safety tolerability Argatroban hemodialysis patient . The secondary goal study assess adequacy anticoagulation hemodialysis .</brief_summary>
	<brief_title>Pharmacokinetics/Pharmacodynamics Argatroban Injection End-Stage Renal Disease Patients Undergoing Hemodialysis</brief_title>
	<detailed_description />
	<mesh_term>Kidney Diseases</mesh_term>
	<mesh_term>Kidney Failure , Chronic</mesh_term>
	<mesh_term>Renal Insufficiency , Chronic</mesh_term>
	<mesh_term>Renal Insufficiency</mesh_term>
	<mesh_term>Argatroban</mesh_term>
	<criteria>Basic 1 . Patients , adult men woman 21 75 year age maintenance hemodialysis regimen least three ( 3 ) month prior study start . 2 . Patients tolerate hemodialysis session last 9 hour . 3 . Patients tolerate hemodialysis treatment blood flow rate 300 ml per minute . 4 . Female volunteer document surgically sterile must willing abstain sexual intercourse study willing use intrauterine device 2 form barrier contraception least 7 day prior initial dose study medication continue completion study . Basic 1 . Any clinically relevant abnormality identify per investigator screen medical assessment laboratory examination . 2 . History regular alcohol abuse . 3 . Treatment investigational drug within 30 day . 4 . History drug allergy clinical significance opinion investigator . 5 . Currently take warfarin anticoagulant . 6 . Currently take NSAIDs ( exception aspirin ) . 7 . Individuals obese . 8 . Any history bleeding disorder . 9 . Any subject screening rest systolic blood pressure &gt; 180 mmHg and/or rest diastolic blood pressure &gt; 100 mmHg unless , opinion principal investigator , blood pressure would endanger subject participate trial . 10 . Concurrent uncontrolled cardiovascular , hematologic , respiratory , CNS , gastrointestinal disease chronic alcoholism . 11 . Anemia define hematocrit &lt; 30 hemoglobin &lt; 10g/dL . 12 . Concurrently take ( within past 30 day ) phenytoin , cimetidine , rifampin , cyclosporin tacrolimus . 13 . Known hypersensitivity Argatroban related compound . 14 . Significant hepatic insufficiency define total bilirubin great 1.5 mg/dL transaminase ( ALT , AST ) elevation great 2 time upper limit laboratory reference range .</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>December 2003</verification_date>
	<keyword>ESRD</keyword>
	<keyword>End-stage renal disease</keyword>
	<keyword>Hemodialysis</keyword>
</DOC>